Keep upto date with the latest medical innovations
Impact of Nucleoside Analogue Therapy on Morbidity and Mortality of Chronic Hepatitis B
In this study appearing in the recent edition of European Gastroenterology Review 2006,
Berlian Idris and colleagues quantify the long-term impact of lamivudine therapy and viral
resistance against it on mortality and morbidity using Markov cohortsimulation.
Figure 1a: Survival Probability of HBeAg-positive Chronic Hepatitis B
Figure 1b: Survival Probability of HBeAg-negative Chronic Hepatitis B
Impact of Nucleoside Analogue Therapy on Morbidity and Mortality of Chronic HepatitisB